Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.

PubWeight™: 3.39‹?› | Rank: Top 1%

🔗 View Article (PMID 14519706)

Published in JAMA on October 01, 2003

Authors

Anette-G Ziegler1, Sandra Schmid, Doris Huber, Michael Hummel, Ezio Bonifacio

Author Affiliations

1: Diabetes Research Institute and Hospital München-Schwabing, Munich, Germany. anziegler@lrz.uni-muenchen.de

Articles citing this

(truncated to the top 100)

Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med (2010) 4.16

Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med (2012) 3.35

Infant exposures and development of type 1 diabetes mellitus: The Diabetes Autoimmunity Study in the Young (DAISY). JAMA Pediatr (2013) 2.92

The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes (2008) 2.77

Type 1 diabetes: recent developments. BMJ (2004) 2.66

The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci (2008) 2.65

Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A (2005) 2.06

Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am (2010) 2.02

Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol (2013) 1.65

Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A (2005) 1.65

Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation. Rheum Dis Clin North Am (2010) 1.60

Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes. Diabetes (2010) 1.48

Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun (2012) 1.43

Management of diabetes mellitus in infants. Nat Rev Endocrinol (2011) 1.40

Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39

Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care (2011) 1.38

The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.30

Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.25

Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr (2008) 1.24

Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev (2013) 1.21

Questions persist: environmental factors in autoimmune disease. Environ Health Perspect (2011) 1.21

Methods for the year 6 follow-up study of children in the Infant Feeding Practices Study II. Pediatrics (2014) 1.15

Age at first introduction to complementary foods is associated with sociodemographic factors in children with increased genetic risk of developing type 1 diabetes. Matern Child Nutr (2013) 1.10

The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia (2010) 1.10

The Impact of Diet Wheat Source on the Onset of Type 1 Diabetes Mellitus-Lessons Learned from the Non-Obese Diabetic (NOD) Mouse Model. Nutrients (2017) 1.07

Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care (2008) 1.05

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA (2014) 1.04

Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci (2013) 1.02

Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes (2009) 1.02

Immune therapy in type 1 diabetes mellitus. Nat Rev Endocrinol (2013) 1.02

The intestinal microbiome in type 1 diabetes. Clin Exp Immunol (2014) 1.02

Early feeding and risk of celiac disease in a prospective birth cohort. Pediatrics (2013) 1.01

An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes (2009) 1.00

Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes (2011) 0.99

Identification of three wheat globulin genes by screening a Triticum aestivum BAC genomic library with cDNA from a diabetes-associated globulin. BMC Plant Biol (2009) 0.96

The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov Med (2012) 0.96

Infant and childhood diet and type 1 diabetes risk: recent advances and prospects. Curr Diab Rep (2010) 0.94

Primary and secondary prevention of Type 1 diabetes. Diabet Med (2013) 0.94

Dietary gluten and the development of type 1 diabetes. Diabetologia (2014) 0.94

Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes. Mamm Genome (2009) 0.92

Perinatal and early childhood risk factors associated with rheumatoid factor positivity in a healthy paediatric population. Ann Rheum Dis (2007) 0.91

Achieving antigen-specific immune regulation. J Clin Invest (2004) 0.90

Infant feeding patterns over the first year of life: influence of family characteristics. Eur J Clin Nutr (2013) 0.90

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. Diabetes (2016) 0.88

Gluten related disorders. Gastroenterol Hepatol Bed Bench (2012) 0.88

Nutritional factors and preservation of C-peptide in youth with recently diagnosed type 1 diabetes: SEARCH Nutrition Ancillary Study. Diabetes Care (2013) 0.87

The gut microbiota and Type 1 Diabetes. Clin Immunol (2015) 0.87

Early infant feeding and type 1 diabetes. Eur J Nutr (2009) 0.85

Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice. PLoS One (2012) 0.85

Infant feeding patterns in families with a diabetes history - observations from The Environmental Determinants of Diabetes in the Young (TEDDY) birth cohort study. Public Health Nutr (2013) 0.85

Early childhood infections and the risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care (2012) 0.85

Blood-based signatures in type 1 diabetes. Diabetologia (2015) 0.84

Effect of dietary gluten on dendritic cells and innate immune subsets in BALB/c and NOD mice. PLoS One (2015) 0.84

Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study. Diabetes (2012) 0.84

Steep increase of incidence of childhood diabetes since 1999 in Austria. Time trend analysis 1979-2005. A nationwide study. Eur J Pediatr (2007) 0.83

Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth. Diabetes Care (2010) 0.83

Celiac disease: presentation of 109 children. Yonsei Med J (2009) 0.83

Recommendations on complementary feeding for healthy, full-term infants. Ital J Pediatr (2015) 0.82

Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis. Curr Diab Rep (2014) 0.82

A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice. Clin Exp Immunol (2014) 0.81

Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev Diabet Stud (2004) 0.80

Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives. Mol Metab (2016) 0.80

Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr (2013) 0.80

Type 1 diabetes: A predictable disease. World J Diabetes (2015) 0.80

Potential beneficial effects of a gluten-free diet in newly diagnosed children with type 1 diabetes: a pilot study. Springerplus (2016) 0.80

The Role of Gluten in Celiac Disease and Type 1 Diabetes. Nutrients (2015) 0.79

Celiac disease beyond the gut. Clin Gastroenterol Hepatol (2008) 0.79

Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet. Gut (2006) 0.79

Risk factors and primary prevention trials for type 1 diabetes. Int J Biol Sci (2013) 0.78

Cost-Effectiveness of Peer Counselling for the Promotion of Exclusive Breastfeeding in Uganda. PLoS One (2015) 0.77

Nutritional status, growth and disease management in children with single and dual diagnosis of type 1 diabetes mellitus and coeliac disease. BMC Gastroenterol (2014) 0.77

Insulin autoantibodies with high affinity to the bovine milk protein alpha casein. Clin Exp Immunol (2011) 0.77

Dietary iron intake in the first 4 months of infancy and the development of type 1 diabetes: a pilot study. Diabetol Metab Syndr (2010) 0.77

Metabolomics makes a mark: early changes associated with autoimmune diabetes. Diabetes (2011) 0.77

Maternal microchimerism: friend or foe in type 1 diabetes? Chimerism (2014) 0.77

Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease. Rheum Dis Clin North Am (2014) 0.77

Early exclusive breastfeeding is associated with longer telomeres in Latino preschool children. Am J Clin Nutr (2016) 0.76

The role of infant nutrition in the prevention of future disease. Front Pediatr (2014) 0.76

Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy. Diabetol Metab Syndr (2016) 0.76

Infant feeding and risk of developing celiac disease: a systematic review. BMJ Open (2016) 0.76

Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome (2016) 0.76

Infant diets and type 1 diabetes: too early, too late, or just too complicated? JAMA (2003) 0.76

Psychological stress and coeliac disease in childhood: a cohort study. BMC Gastroenterol (2010) 0.76

Engineering the gut for insulin replacement to treat diabetes. J Diabetes Investig (2016) 0.75

Growth and Risk for Islet Autoimmunity and Progression to Type 1 Diabetes in Early Childhood: The Environmental Determinants of Diabetes in the Young Study. Diabetes (2016) 0.75

Environmental trigger(s) of type 1 diabetes: why so difficult to identify? Biomed Res Int (2015) 0.75

Protective environmental factors for neuromyelitis optica. Neurology (2014) 0.75

The next big idea. Diabetes Technol Ther (2013) 0.75

Primary prevention for type 1 diabetes mellitus? Nat Rev Endocrinol (2015) 0.75

Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults: an explorative case control study. PLoS One (2014) 0.75

Timing of solid food introduction is associated with urinary F2-isoprostane concentrations in childhood. Pediatr Res (2015) 0.75

Mucosal immunity and type 1 diabetes: looking at the horizon beyond cow's milk. Pediatr Diabetes (2008) 0.75

The association between IgG4 antibodies to dietary factors, islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. PLoS One (2013) 0.75

Type-specific human papillomavirus detection in cervical smears in Romania. APMIS (2010) 0.75

Gluten intake in 6-36-month-old Danish infants and children based on a national survey. J Nutr Sci (2013) 0.75

Infant Feeding and Timing of Complementary Foods in the Development of Type 1 Diabetes. Curr Diab Rep (2015) 0.75

Diet Quality during Infancy and Early Childhood in Children with and without Risk of Type 1 Diabetes: A DEDIPAC Study. Nutrients (2017) 0.75

Celiac disease: From pathophysiology to treatment. World J Gastrointest Pathophysiol (2017) 0.75

The effects of formula feeding on physiological and immunological parameters in the gut of neonatal rats. Dig Dis Sci (2008) 0.75

Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development. Proc Natl Acad Sci U S A (2017) 0.75

Articles by these authors

Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med (2014) 5.44

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA (2013) 3.65

Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes (2003) 3.09

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood (2013) 3.03

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood (2007) 2.82

Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes (2004) 2.74

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes (2008) 2.60

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood (2005) 2.39

Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest (2004) 2.34

Predictors of overweight during childhood in offspring of parents with type 1 diabetes. Diabetes Care (2009) 2.31

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol (2005) 2.31

Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med (2004) 2.31

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97

A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med (2010) 1.93

Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One (2011) 1.87

Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest (2008) 1.73

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood (2013) 1.71

Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations. Genes Dev (2011) 1.69

Natural history of type 1 diabetes. Diabetes (2005) 1.68

Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature (2013) 1.66

Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes (2006) 1.65

Bone marrow as an alternative site for islet transplantation. Blood (2009) 1.61

Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects. Diabetes Care (2002) 1.59

Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease. Hematology Am Soc Hematol Educ Program (2003) 1.56

IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL. Blood (2013) 1.55

Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol (2007) 1.49

Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Diabetes (2008) 1.49

Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes (2006) 1.48

Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood (2008) 1.47

Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines. Leuk Res (2009) 1.47

Primary and secondary prevention of cardiovascular disease in diabetes with aspirin. Diab Vasc Dis Res (2012) 1.45

PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2013) 1.44

Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.44

Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol (2002) 1.43

Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care (2009) 1.42

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes (2011) 1.39

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood (2011) 1.39

Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care (2011) 1.38

Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol (2003) 1.37

Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes (2006) 1.35

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL. Blood (2010) 1.33

Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood (2005) 1.30

IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care (2004) 1.29

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood (2012) 1.27

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care (2010) 1.26

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells. Blood (2005) 1.24

Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood (2004) 1.23

Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood (2011) 1.22

High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases. Genomics (2003) 1.22

Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One (2011) 1.22

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care (2004) 1.21

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol (2010) 1.21

The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia (2015) 1.20

Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. J Pathol (2003) 1.19

Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes (2004) 1.18

Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization. Curr Diab Rep (2008) 1.15

Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma. Haematologica (2008) 1.15

GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes (2007) 1.15

Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes (2011) 1.14

Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol (2002) 1.13

Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. Clin Immunol (2006) 1.13

Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol (2004) 1.12

Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol (2004) 1.12

CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. Am J Pathol (2008) 1.11

A genomic toolkit to investigate kinesin and myosin motor function in cells. Nat Cell Biol (2013) 1.11

CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation. J Pathol (2004) 1.11

Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A (2013) 1.10

CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08

Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice. Clin Immunol (2004) 1.08

Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immunol (2004) 1.07

Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function. Stem Cells (2010) 1.07

Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity. Haematologica (2010) 1.07

Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer (2009) 1.06

5,5'-Azoxytetrazolates--a new nitrogen-rich dianion and its comparison to 5,5'-azotetrazolate. Dalton Trans (2012) 1.06

Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci (2005) 1.06

CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J Clin Invest (2012) 1.05

Molecular profiles and clinical outcome of stage UICC II colon cancer patients. Int J Colorectal Dis (2011) 1.05

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica (2013) 1.05

Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children. J Autoimmun (2011) 1.04

Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab (2003) 1.03

Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer (2010) 1.03

An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes (2011) 1.02

SLC30A8 (ZnT8) Polymorphism is Associated with Young Age at Type 1 Diabetes Onset. Rev Diabet Stud (2008) 1.02

Role of CCL2/MCP-1 in islet transplantation. Cell Transplant (2010) 1.01

MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med (2012) 1.01

Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer. BMC Genomics (2010) 1.01

Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol (2008) 1.00

Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes (2012) 0.99

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria. J Thorac Oncol (2014) 0.98

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood (2014) 0.98

The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice. Ann N Y Acad Sci (2003) 0.98

IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells. J Immunol (2012) 0.98

Transplant estimated function: a simple index to evaluate beta-cell secretion after islet transplantation. Diabetes Care (2007) 0.98

Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol (2005) 0.98

Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing. Lung Cancer (2013) 0.97